Clinical Trials Directory

Trials / Completed

CompletedNCT02867449

Metacognitive Therapy for Obsessive-Compulsive Disorder

A Non-Inferiority Trial of Metacognitive Therapy Versus Exposure and Response Prevention for Individuals With Obsessive-Compulsive Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
74 (actual)
Sponsor
University of Leipzig · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Cognitive behavior therapy is the most effective treatment of obsessive-compulsive disorder. However, the majority of treated patients remain symptomatic. The metacognitive therapy by Wells (1997) could achieve substantial gains in first pilot studies. The purpose of this study is to investigate this approach with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder.

Detailed description

The purpose of this study is to investigate metacognitive therapy by Wells (1997) with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMetacognitive TherapyMetacognitive Therapy for OCD according to Wells (1997)
BEHAVIORALExposure and Response PreventionExposure and Response Prevention for OCD according to Kozak \& Foa (1997)

Timeline

Start date
2016-06-01
Primary completion
2020-01-01
Completion
2020-01-01
First posted
2016-08-16
Last updated
2021-09-28

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT02867449. Inclusion in this directory is not an endorsement.